Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease

被引：0
|
作者：
Donald P. Tashkin
Nicola A. Hanania
Joe McGinty
Kimberly Denis-Mize
Imtiaz Chaudry
机构：
[1] David Geffen School of Medicine at UCLA,Division of Pulmonary and Critical Care Medicine
[2] Baylor College of Medicine,Division of Pulmonary and Critical Care Medicine
[3] Dey Pharma LP,undefined
来源：
Advances in Therapy | 2009年 / 26卷
关键词：
chronic obstructive pulmonary disease; formoterol; long-acting beta; agonist; maintenance therapy; nebulization; tiotropium;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1024 / 1034
页数：10
相关论文
共 50 条
  • [31] Aclidinium bromide plus formoterol for the treatment of chronic obstructive pulmonary disease
    Lal, Chitra
    Strange, Charlie
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (03) : 427 - 434
  • [32] Formoterol fumarate plus glycopyrrolate for the treatment of chronic obstructive pulmonary disease
    Radovanovic, Dejan
    Mantero, Marco
    Papa, Giuseppe Francesco Sferrazza
    Valenti, Vincenzo
    Aliberti, Stefano
    Di Marco, Fabiano
    Santus, Pierachille
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (10) : 1045 - 1055
  • [33] Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary disease
    Campbell, M
    Eliraz, A
    Johansson, G
    Tornling, G
    Nihlén, U
    Bengtsson, T
    Rabe, KF
    RESPIRATORY MEDICINE, 2005, 99 (12) : 1511 - 1520
  • [34] Tiotropium plus formoterol versus tiotropium alone for stable moderate-to-severe chronic obstructive pulmonary disease: Ameta-analysis
    Zou, Yong
    Xiao, Jian
    Lu, Xiao Xiao
    Xia, Zi An
    Xie, Bin
    Li, Jun
    Chen, Qiong
    CLINICAL RESPIRATORY JOURNAL, 2018, 12 (01): : 269 - 278
  • [35] Tiotropium versus placebo for chronic obstructive pulmonary disease
    Karner, Charlotta
    Chong, Jimmy
    Poole, Phillippa
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (07):
  • [36] Combined Therapy with Tiotropium and Formoterol in Chronic Obstructive Pulmonary Disease: Effect on the 6-Minute Walk Test
    Jayaram, Lata
    Wong, Conroy
    McAuley, Sue
    Rea, Harry
    Zeng, Irene
    O'Dochartaigh, Conor
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2013, 10 (04) : 466 - 472
  • [37] A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease
    van Noord, JA
    Bantje, TA
    Eland, ME
    Korducki, L
    Cornelissen, PJG
    THORAX, 2000, 55 (04) : 289 - 294
  • [38] Evaluating Characteristics Of Chronic Obstructive Pulmonary Disease (COPD) Patients New To Controller Treatment: Budesonide/formoterol Combination (bfc) Versus Tiotropium
    Williams, S.
    Trudo, F.
    Kern, D.
    Wessman, C.
    Tunceli, O.
    Zhou, S.
    Pethick, N.
    Elhefni, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [39] Pharmacoeconomic evaluation of tiotropium in the treatment of patients with chronic obstructive pulmonary disease in Spain
    De Lucas, P
    Rodríguez, JM
    Gobartt, E
    Soto, J
    Martin, A
    VALUE IN HEALTH, 2005, 8 (06) : A212 - A213
  • [40] Tiotropium: An inhaled anticholinergic for chronic obstructive pulmonary disease
    Olin, JL
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (12) : 1263 - 1269
12345